Enanta Pharmaceuticals (ENTA) Consolidated Net Income (2012 - 2026)
Enanta Pharmaceuticals (ENTA) reported Consolidated Net Income of -$19.5 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$18.26 million a year earlier.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Consolidated Net Income (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enanta Pharmaceuticals' Consolidated Net Income came in at -$63.23 million; for FY2025 (ended Sep 30, 2025), it came in at -$81.89 million.
- By fiscal year, Consolidated Net Income came in at -$116.05 million in FY2024, -$133.82 million in FY2023, -$121.76 million in FY2022 and -$79 million in FY2021.
- The fiscal Q3 2026 figure ranks as the lowest quarterly Consolidated Net Income since fiscal Q2 2025.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$13.09 million (Q2 2026), -$11.94 million (Q1 2026) and -$18.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Enanta Pharmaceuticals | 377.40 Mn | -350.60 Mn | - | -19.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.50 Mn |
| Mar 31, 2026 | -13.09 Mn |
| Dec 31, 2025 | -11.94 Mn |
| Sep 30, 2025 | -18.70 Mn |
| Jun 30, 2025 | -18.26 Mn |
| Mar 31, 2025 | -22.64 Mn |
| Dec 31, 2024 | -22.29 Mn |
| Sep 30, 2024 | -28.82 Mn |
| Jun 30, 2024 | -22.66 Mn |
| Mar 31, 2024 | -31.16 Mn |
| Dec 31, 2023 | -33.41 Mn |
| Sep 30, 2023 | -28.11 Mn |
| Jun 30, 2023 | -39.07 Mn |
| Mar 31, 2023 | -37.66 Mn |
| Dec 31, 2022 | -28.99 Mn |
| Sep 30, 2022 | -26.35 Mn |
| Jun 30, 2022 | -31.70 Mn |
| Mar 31, 2022 | -33.59 Mn |
| Dec 31, 2021 | -30.12 Mn |
| Sep 30, 2021 | -24.60 Mn |
API Access
Enanta Pharmaceuticals Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();